BioCentury | May 11, 2018
Clinical News

Boehringer's Stiolto Respimat misses in Phase III for COPD

...severe COPD exacerbations vs. Spiriva Respimat tiotropium bromide. Stiolto Respimat non-significantly decreased the rate by 7% vs. Spiriva Respimat...
BioCentury | Dec 1, 2017
Clinical News

Duaklir Genuair meets in Phase III to treat COPD

...aclidinium bromide or formoterol alone. Duaklir Genuair also met the co-primary endpoint of non-inferiority to tiotropium bromide...
BioCentury | Feb 17, 2017
Clinical News

Spiriva Respimat regulatory update

...FDA approved Spiriva Respimat tiotropium bromide from Boehringer for long-term maintenance treatment of asthma in patients ages 6-11...
...in patients ages 6-11. The drug is marketed for the indication in patients ages ≥12. Spiriva Respimat...
...via the Respimat Inhaler. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide Business: Inflammation Julian Zhu Spiriva Respimat tiotropium bromide Boehringer...
BioCentury | Sep 19, 2016
Clinical News

Spiriva Respimat tiotropium bromide: Phase III data

...taking an inhaled corticosteroid with 1-2 other controller medications showed that once-daily 5 ug inhaled Spiriva Respimat...
...baseline to week 12 vs. placebo (improvement of 13.8 L, p=0.0089). Once-daily 2.5 ug inhaled Spiriva Respimat...
...disease (COPD) and for reducing COPD exacerbations. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
BioCentury | Sep 19, 2016
Clinical News

Spiriva Respimat tiotropium bromide: Phase III data

...inhaled corticosteroid with 1-2 other controller medications showed that once-daily 2.5 and 5 ug inhaled Spiriva Respimat...
...week 48 vs. placebo. Data were presented at the European Respiratory Society meeting in London. Spiriva Respimat...
...disease (COPD) and for reducing COPD exacerbations. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
BioCentury | Sep 19, 2016
Clinical News

Spiriva Respimat tiotropium bromide: Phase III data

...taking an inhaled corticosteroid with 1-2 other controller medications showed that once-daily 5 ug inhaled Spiriva Respimat...
...placebo (improvements of 17.4 and 17.6 L/min, respectively, p=0.005 and p=0.0004). Once-daily 2.5 ug inhaled Spiriva Respimat...
...disease (COPD) and for reducing COPD exacerbations. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
BioCentury | Sep 19, 2016
Clinical News

Spiriva Respimat tiotropium bromide: Phase III data

...corticosteroid with or without another controller medication showed that once-daily 2.5 and 5 ug inhaled Spiriva Respimat...
...placebo (p<0.0001 for both). Data were presented at the European Respiratory Society meeting in London. Spiriva Respimat...
...disease (COPD) and for reducing COPD exacerbations. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
BioCentury | Sep 19, 2016
Clinical News

Spiriva Respimat tiotropium bromide: Phase II/III data

...corticosteroid with or without another controller medication showed that once-daily 2.5 and 5 ug inhaled Spiriva Respimat...
...of patients receiving placebo. Data were presented at the European Respiratory Society meeting in London. Spiriva Respimat...
...disease (COPD) and for reducing COPD exacerbations. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
BioCentury | Sep 21, 2015
Clinical News

Spiriva Respimat tiotropium bromide regulatory update

...FDA approved Spiriva Respimat tiotropium bromide inhalation spray from Boehringer for long-term, once-daily, add-on maintenance treatment of asthma...
...spray from Boehringer for long-term, once-daily, add-on maintenance treatment of asthma in patients ages >=12. Spiriva Respimat...
...antagonist (LAMA) -- via the Respimat Inhaler. Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
BioCentury | Mar 2, 2015
Clinical News

Spiriva Respimat tiotropium bromide: Phase III data

...The MezzoTinA-asthma trials are part of the Phase III UniTinA-asthma program, which is evaluating Spiriva Respimat in...
...treatment of asthma in patients ages >=12 years who remain symptomatic on at least ICS. Spiriva Respimat...
...marketed for chronic obstructive pulmonary disease (COPD). Boehringer Ingelheim GmbH , Ingelheim, Germany Product: Spiriva Respimat tiotropium bromide...
Items per page:
1 - 10 of 53